Relugolix Pregnancy Registry: An Observational Study of the Safety of Relugolix-Containing Therapy Exposure in Pregnant Women and Their Offspring

NCT05739123 · clinicaltrials.gov ↗

RECRUITING

Status

728

Enrollment

INDUSTRY

Sponsor class

Conditions

Pregnancy Related
Pregnancy Complications
Pregnancy, High Risk

Interventions

DRUG: Relugolix-Containing Product

Sponsor

Sumitomo Pharma Switzerland GmbH